No painful procedure or biopsy needed. We can test our blood to diagnose and even predict cancer.
The Human Genome Project, a joint effort between the U.S. Department of Energy and the National Institutes of Health, began...more
Does your morning coffee need a warning label other than “Caution: Contents Hot”? A California judge doesn’t think so.
In August, a California judge ended a decade long lawsuit alleging that dozens of coffee roasters and...more
On August 26, 2020, the U.S. Food and Drug Administration approved Foundation Medicine, Inc.’s Foundation One® Liquid CDx, a quantitative next-generation sequencing (NGS) test that can detect mutations using circulating...more
The Food and Drug Administration’s approval of Guardant Health’s Guardant360 CDx assay marks a new era for genetic mutation testing in cancer treatment. On August 7, 2020, the FDA approved the first diagnostic test that...more